Sharon Hillier
#74,288
Most Influential Person Now
American microbiologist
Sharon Hillier's AcademicInfluence.com Rankings
Sharon Hillierbiology Degrees
Biology
#5278
World Rank
#7720
Historical Rank
Microbiology
#247
World Rank
#288
Historical Rank
Download Badge
Biology
Sharon Hillier's Degrees
- PhD Microbiology University of California, San Francisco
- Bachelors Biology University of California, Santa Cruz
Similar Degrees You Can Earn
Why Is Sharon Hillier Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sharon Louise Hillier is an American microbiologist. She is the Richard Sweet Endowed Chair in Reproductive Infectious Disease and vice chair of the department of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh Medical Center and Magee-Women's Research Institute.
Sharon Hillier's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation (1991) (3003)
- Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant (1995) (1286)
- Tenofovir-based preexposure prophylaxis for HIV infection among African women. (2015) (1081)
- A review of premature birth and subclinical infection. (1992) (906)
- Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. (1999) (877)
- Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery (1997) (825)
- The Relationship of Amniotic Fluid Cytokines and Preterm Delivery, Amniotic Fluid Infection, Histologic Chorioamnionitis, and Chorioamnion Infection (1993) (614)
- In Vitro and In Vivo: The Story of Nonoxynol 9 (2005) (592)
- Diagnosis and clinical manifestations of bacterial vaginosis. (1988) (533)
- Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. (1996) (530)
- Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. (2003) (508)
- The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. (1999) (488)
- A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. (1988) (486)
- Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. (1995) (485)
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. (2016) (470)
- Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. (2000) (470)
- The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. (1992) (445)
- The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. (1993) (444)
- Control of the microbial flora of the vagina by H2O2-generating lactobacilli. (1991) (432)
- Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. (2001) (407)
- Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. (2002) (378)
- Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. (2003) (376)
- Relationships of Vaginal Lactobacillus species, Cervical Chlamydia trachomatis, and Bacterial Vaginosis to Preterm Birth (1988) (307)
- Lower Genital Tract Infection and Endometritis: Insight Into Subclinical Pelvic Inflammatory Disease (2002) (299)
- HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis (1997) (292)
- A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. (2005) (288)
- Bacterial Vaginosis as a Risk Factor for Post- Cesarean Endometritis (1990) (285)
- Detection of HIV DNA in cervical and vaginal secretions: Prevalence and correlates among women in Nairobi, Kenya (1993) (269)
- Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. (2002) (263)
- Validity of the Vaginal Gram Stain for the Diagnosis of Bacterial Vaginosis (1996) (258)
- An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). (2001) (258)
- Diagnostic microbiology of bacterial vaginosis. (1993) (251)
- Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand (1995) (244)
- Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. (2006) (241)
- Douching in Relation to Bacterial Vaginosis, Lactobacilli, and Facultative Bacteria in the Vagina (2002) (237)
- Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women (2011) (236)
- Bacterial vaginosis and anaerobic bacteria are associated with endometritis. (2004) (235)
- A Delicate Balance: Risk Factors for Acquisition of Bacterial Vaginosis Include Sexual Activity, Absence of Hydrogen Peroxide-Producing Lactobacilli, Black Race, and Positive Herpes Simplex Virus Type 2 Serology (2008) (234)
- Clinical manifestations of vaginal trichomoniasis. (1989) (233)
- Combination HIV prevention for female sex workers: what is the evidence? (2015) (217)
- Microbiologic causes and neonatal outcomes associated with chorioamnion infection. (1991) (217)
- Group B Streptococcal Colonization and Serotype‐Specific Immunity in Pregnant Women at Delivery (2000) (211)
- Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4 (2003) (207)
- Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. (2001) (207)
- Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. (1991) (205)
- Bacterial colonization of the vagina during pregnancy in four ethnic groups. (1996) (204)
- Role of bacterial vaginosis-associated microorganisms in endometritis. (1996) (199)
- Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. (2000) (197)
- Characteristics of three vaginal flora patterns assessed Gram stain among pregnant women (1992) (197)
- Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. (2005) (194)
- Sexually transmitted diseases in victims of rape. (1990) (193)
- Antenatal microbiologic and maternal risk factors associated with prematurity. (1990) (188)
- Predictive value of the clinical diagnosis of lower genital tract infection in women. (2004) (187)
- Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. (1995) (183)
- Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora (1992) (182)
- Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. (2005) (181)
- Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy (1998) (179)
- Subclinical Pelvic Inflammatory Disease and Infertility (2012) (179)
- Antimicrobial resistance associated with the treatment of bacterial vaginosis. (2004) (173)
- Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. (2007) (169)
- Biological and Technical Variables Affecting Immunoassay Recovery of Cytokines from Human Serum and Simulated Vaginal Fluid: A Multicenter Study (2008) (163)
- Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. (1994) (161)
- Bacterial Vaginosis and Risk of Pelvic Inflammatory Disease (2004) (160)
- The vaginal microbial ecosystem and resistance to HIV. (1998) (157)
- Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor. (1997) (155)
- The Associations Between Pelvic Inflammatory Disease, Trichomonas vaginalis Infection, and Positive Herpes Simplex Virus Type 2 Serology (2006) (155)
- Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus (2008) (154)
- HIV infection and vaginal douching in Central Africa (1997) (145)
- Vaginal Indicators of Amniotic Fluid Infection in Preterm Labor (2001) (144)
- Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. (1993) (144)
- Comparison of methods for diagnosing bacterial vaginosis among pregnant women (1989) (143)
- Comparison of Acute and Subclinical Pelvic Inflammatory Disease (2005) (143)
- Escherichia coli bacteriuria and contraceptive method. (1991) (139)
- Comparative Genomic Analyses of 17 Clinical Isolates of Gardnerella vaginalis Provide Evidence of Multiple Genetically Isolated Clades Consistent with Subspeciation into Genovars (2012) (138)
- Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. (1997) (137)
- Risk Factors for Infection With Herpes Simplex Virus Type 2:: Role of Smoking, Douching, Uncircumcised Males, and Vaginal Flora (2003) (137)
- Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. (2007) (132)
- Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? (2003) (131)
- Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. (2005) (130)
- Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. (2003) (130)
- Sialidase (neuraminidase) activity among gram-negative anaerobic and capnophilic bacteria (1990) (129)
- Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs. (2006) (125)
- Evaluation of affirm VP Microbial Identification Test for Gardnerella vaginalis and Trichomonas vaginalis (1994) (122)
- Microbiologic Characteristics of Lactobacillus Products Used for Colonization of the Vagina (1990) (121)
- Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. (2014) (119)
- The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. (1995) (119)
- Maternal peripartum complications associated with vaginal group B streptococci colonization. (1999) (117)
- Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? (2005) (116)
- The Genital Flora of Women with Intraamniotic Infection (1995) (116)
- The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. (1992) (115)
- Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. (2000) (115)
- Optimization of Media for Detection of Hydrogen Peroxide Production by Lactobacillus Species (2003) (114)
- Amniotic Fluid Infection, Cytokines, and Adverse Outcome Among Infants at 34 Weeks' Gestation or Less (2001) (110)
- Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants. (1997) (110)
- Clinical and Cervical Cytokine Response to Treatment With Oral or Vaginal Metronidazole for Bacterial Vaginosis During Pregnancy: A Randomized Trial (2003) (108)
- Glycosidase and Proteinase Activity of Anaerobic Gram-Negative Bacteria Isolated From Women With Bacterial Vaginosis (2003) (103)
- Comparison of API 50 CH Strips to Whole-Chromosomal DNA Probes for Identification of Lactobacillus Species (2005) (103)
- Race/ethnicity, vaginal flora patterns, and pH during pregnancy. (1999) (103)
- Bacterial Vaginosis: Identifying Research Gaps Proceedings of a Workshop Sponsored by DHHS/NIH/NIAID (2010) (101)
- Preclinical Safety and Efficacy Assessments of Dendrimer-Based (SPL7013) Microbicide Gel Formulations in a Nonhuman Primate Model (2006) (101)
- Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. (1995) (99)
- Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. (2009) (93)
- Microbiologic Response to Treatment of Bacterial Vaginosis with Topical Clindamycin or Metronidazole (2005) (92)
- Efficacy of Intravaginal 0.75% Metronidazole Gel for the Treatment of Bacterial Vaginosis (1993) (90)
- Genital flora in pregnancy and its association with intrauterine growth retardation (1994) (90)
- Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications. (1997) (90)
- DNA Fingerprinting of Lactobacilluscrispatus Strain CTV-05 by Repetitive Element Sequence-Based PCR Analysis in a Pilot Study of Vaginal Colonization (2003) (90)
- Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. (2002) (88)
- Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. (2003) (88)
- Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. (1996) (87)
- Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis (1990) (87)
- Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. (2003) (86)
- Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. (2000) (86)
- Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. (2006) (86)
- Distribution of genital Lactobacillus strains shared by female sex partners. (2004) (84)
- Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women. (2003) (84)
- Douching and Endometritis: Results From the PID Evaluation and Clinical Health (PEACH) Study (2001) (83)
- Risk factors for cervicitis among women with bacterial vaginosis. (2006) (81)
- Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. (2000) (80)
- Impact of contraceptive initiation on vaginal microbiota (2018) (80)
- Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). (1999) (79)
- Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators (2011) (79)
- Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis. (2005) (77)
- Hepatitis C Virus Screening Among Children Exposed During Pregnancy (2018) (77)
- Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial (2007) (76)
- Elevated vaginal pH and neutrophils are associated strongly with early spontaneous preterm birth. (2003) (75)
- Bacteremia shortly after placental separation during Cesarean delivery (1996) (74)
- Use of Nucleic Acid Amplification Testing for Diagnosis of Anorectal Sexually Transmitted Infections (2012) (71)
- Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Strand Displacement Amplification and Relevance of the Amplification Control for Use with Vaginal Swab Specimens (2003) (70)
- Preclinical Safety Assessments of UC781 Anti-Human Immunodeficiency Virus Topical Microbicide Formulations (2007) (69)
- Genetic basis of tetracycline resistance in urogenital bacteria (1990) (69)
- The Vaginal Microflora of Pig‐Tailed Macaques and the Effects of Chlorhexidine and Benzalkonium on This Ecosystem (1996) (67)
- Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. (1998) (67)
- The complexity of microbial diversity in bacterial vaginosis. (2005) (66)
- Racial disparity in risk of preterm birth associated with lower genital tract infection. (2007) (66)
- Vaginal hydrolytic enzymes, immunoglobulin A against Gardnerella vaginalis toxin, and risk of early preterm birth among women in preterm labor with bacterial vaginosis or intermediate flora. (2002) (66)
- Why Women Douche and Why They May or May Not Stop (2003) (64)
- Prevention of Sexually Transmitted Diseases (STDs) in Female Sex Workers: Prospective Evaluation of Condom Promotion and Strengthened STD Services (2003) (64)
- Comparison of gram stain, DNA probe, and culture for the identification of species of Mobiluncus in female genital specimens. (1985) (63)
- Association of viridans group streptococci from pregnant women with bacterial vaginosis and upper genital tract infection (1988) (62)
- Rectal colonization by group B Streptococcus as a predictor of vaginal colonization. (2009) (62)
- Association between elevated neutrophil defensin levels and endometritis. (2002) (61)
- Longitudinal study of the biotypes of Gardnerella vaginalis (1990) (60)
- Tetracycline resistance and tetM in pathogenic urogenital bacteria (1986) (60)
- A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film (2016) (60)
- Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. (2017) (59)
- Bacterial Vaginosis (BV) and the Risk of Incident Gonococcal or Chlamydial Genital Infection in a Predominantly Black Population (2005) (59)
- The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. (2005) (58)
- Patterns of Extragenital Chlamydia and Gonorrhea in Women and Men Who Have Sex With Men Reporting a History of Receptive Anal Intercourse (2016) (58)
- Pathophysiology and Histopathology of Group B Streptococcal Sepsis in Macaca nemestrina Primates Induced after Intraamniotic Inoculation: Evidence for Bacterial Cellular Invasion (1991) (58)
- Clonal Analysis of Colonizing Group B Streptococcus, Serotype IV, an Emerging Pathogen in the United States (2010) (58)
- The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice. (2009) (58)
- Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin (1989) (56)
- Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. (1999) (56)
- Reproducibility of a scoring system for gram stain diagnosis of bacterial vaginosis (1991) (56)
- Rapid presumptive identification of black-pigmented gram-negative anaerobic bacteria by using 4-methylumbelliferone derivatives (1991) (56)
- Digallate Dimers of (−)-Epigallocatechin Gallate Inactivate Herpes Simplex Virus (2011) (55)
- Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. (2007) (55)
- Rectal Applications of Nonoxynol-9 Cause Tissue Disruption in a Monkey Model (2002) (54)
- Cervicovaginal microflora and pregnancy outcome: Results of a double-blind, placebo-controlled trial of erythromycin treatment (1990) (54)
- Pregnancy Complications Associated With Bacterial Vaginosis and Their Estimated Costs (1995) (53)
- Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. (1992) (53)
- Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. (2015) (53)
- Vaginal Bacteroides Species Are Associated with an Increased Rate of Preterm Delivery among Women in Preterm Labor (1991) (53)
- Cervicovaginal microflora and pregnancy outcome: Results of a double‐blind, placebo‐controlled trial of erythromycin treatment (1991) (52)
- The Occurrence of Vaginal Infections Among HIV-Infected and High-Risk HIV-Uninfected Women: Longitudinal Findings of the Women's Interagency HIV Study (2006) (52)
- The effects of three nonoxynol-9 preparations on vaginal flora and epithelium. (1999) (51)
- The Effect of Treatment Regimens for Vaginitis and Cervicitis on Vaginal Colonization by Lactobacilli (1995) (51)
- Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. (2005) (51)
- The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota (2013) (50)
- Upper Genital Tract Isolates at Delivery as Predictors of Post-Cesarean Infections Among Women Receiving Antibiotic Prophylaxis (1991) (49)
- Use of nonoxynol-9 and changes in vaginal lactobacilli. (1998) (49)
- Vaginal Yeast Colonization in Nonpregnant Women: A Longitudinal Study (2004) (49)
- Effectiveness of Two Tinidazole Regimens in Treatment of Bacterial Vaginosis: A Randomized Controlled Trial (2007) (49)
- Cunnilingus and Vaginal Intercourse Are Risk Factors for Herpes Simplex Virus Type 1 Acquisition in Women (2005) (49)
- Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. (2007) (49)
- The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. (1996) (48)
- The bacterial etiology of conjunctivitis in early infancy. Eye Prophylaxis Study Group. (1993) (47)
- Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women (2018) (47)
- Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. (2021) (47)
- Amoxicillin Treatment of Bacterial Vaginosis During Pregnancy (1991) (47)
- Characteristics of Women in Preterm Labor Associated With Elevated C‐Reactive Protein Levels (1993) (44)
- Formulation and Characterization of Polymeric Films Containing Combinations of Antiretrovirals (ARVs) for HIV Prevention (2015) (44)
- Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study (2020) (43)
- Vaginal Bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. (1991) (43)
- Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products. (2008) (42)
- Characterization of Cyclodextrin Inclusion Complexes of the Anti-HIV Non-Nucleoside Reverse Transcriptase Inhibitor UC781 (2008) (42)
- Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. (1993) (41)
- Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis (2007) (41)
- When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data. (2006) (41)
- The antimicrobial treatment of subacute endometritis: a proof of concept study. (2004) (41)
- Analysis of Factors Driving Incident and Ascending Infection and the Role of Serum Antibody in Chlamydia trachomatis Genital Tract Infection. (2016) (40)
- Permeability of tritiated water through human cervical and vaginal tissue. (2004) (39)
- Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial (2020) (38)
- The effects of reproductive hormones on the physical properties of cervicovaginal fluid. (2014) (38)
- Mucopurulent Cervicitis as a Predictor of Chlamydial Infection and Adverse Pregnancy Outcome (1992) (38)
- Nitrocellulose filter blots for species identification of Mobiluncus curtisii and Mobiluncus mulieris (1984) (38)
- Vaginal and Rectal Topical Microbicide Development: Safety and Efficacy of 1.0% Savvy (C31G) in the Pigtailed Macaque (2006) (37)
- An observational study of empirical antibiotics for adult women with uncomplicated UTI in general practice. (2007) (37)
- Pregnancy-induced changes in immune protection of the genital tract: defining normal. (2013) (37)
- Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. (2006) (37)
- Microflora Changes With the Use of a Vaginal Microbicide (2002) (37)
- Macaca fascicularis vs. Macaca nemestrina as a model for topical microbicide safety studies (2004) (36)
- Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. (2012) (36)
- A new proline aminopeptidase assay for diagnosis of bacterial vaginosis. (1991) (36)
- Changes in genital tract immune cell populations after initiation of intrauterine contraception. (2014) (35)
- Effects of Nonoxynol‐9 on Vaginal Microflora and Chlamydial Infection in a Monkey Model (1996) (35)
- Microbiological, epidemiological and clinical correlates of vaginal colonisation by Mobiluncus species. (1991) (35)
- Cervical anti-inflammatory cytokine concentrations among first-trimester pregnant smokers. (2005) (35)
- How strong is the evidence that antibiotic use is a risk factor for antibiotic-resistant, community-acquired urinary tract infection? (2002) (35)
- Limitations of the Dye-Based Method for Determining Vaginal Applicator Use in Microbicide Trials (2009) (34)
- Mageeibacillus indolicus gen. nov., sp. nov.: a novel bacterium isolated from the female genital tract. (2015) (33)
- High levels of Gardnerella vaginalis detected with an oligonucleotide probe combined with elevated pH as a diagnostic indicator of bacterial vaginosis (1992) (33)
- The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women. (2004) (32)
- Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. (2006) (32)
- HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women (2014) (32)
- Escherichia coli bacteriuria and Contraceptive Method (1991) (32)
- Topical Microbicides in HIV Prevention: State of the Promise. (2020) (31)
- Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B Streptococci. (2000) (31)
- Lactobacillus crispatus Capsules: Single-Use Safety Study in the Macaca nemestrina Model (2003) (31)
- Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings (2020) (31)
- Bacterial species colonizing the vagina of healthy women are not associated with race. (2017) (30)
- Effects of a One Year Reusable Contraceptive Vaginal Ring on Vaginal Microflora and the Risk of Vaginal Infection: An Open-Label Prospective Evaluation (2015) (30)
- Normal vaginal aerobic and anaerobic bacterial flora of the rhesus macaque (Macaca mulatta). (1991) (30)
- A Randomized Controlled Trial of Ceftriaxone and Doxycycline, with or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease. (2020) (30)
- HIV-1 Infection of Female Genital Tract Tissue for Use in Prevention Studies (2013) (29)
- The Pig-tailed Macaque Rectal Model: Microflora and Chlamydial Infection (2001) (29)
- The effect of menopause on the innate antiviral activity of cervicovaginal lavage. (2015) (29)
- Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease. (2014) (29)
- Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection. (2016) (28)
- Effects of Long-Term Use of Nonoxynol-9 on VaginalFlora (2006) (28)
- Improved methods for typing nontypeable isolates of group B streptococci. (2002) (27)
- Survival of Trichomonas vaginalis in wet preparation and on wet mount (2013) (27)
- Standardized Method of Gram Stain Interpretation (27)
- Impact of Bacterial Vaginosis, as Assessed by Nugent Criteria and Hormonal Status on Glycosidases and Lectin Binding in Cervicovaginal Lavage Samples (2015) (27)
- Quantitative Survival of Aerobic and Anaerobic Microorganisms in Port-A-Cul and Copan Transport Systems (2008) (27)
- The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. (2009) (26)
- Effect of Transport Time, Temperature, and Concentration on the Survival of Group B Streptococci in Amies Transport Medium (2004) (26)
- Development of a Nonhuman Primate Model for Trichomonas vaginalis Infection (2006) (25)
- VAGINAL COLONIZATION BY ESCHERICHIA COLI AS A RISK FACTOR FOR VERY LOW BIRTH WEIGHT DELIVERY AND OTHER PERINATAL COMPLICATIONS (1997) (25)
- Antiviral Activity of Genital Tract Secretions After Oral or Topical Tenofovir Pre-exposure Prophylaxis for HIV-1 (2014) (25)
- Incidence and Epidemiology of Streptococcus pseudoporcinus in the Genital Tract (2010) (25)
- Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. (2004) (24)
- DNA Macrorestriction Analysis of Nontypeable Group B Streptococcal Isolates: Clonal Evolution of Nontypeable and Type V Isolates (2005) (24)
- Absence of ageism in access to critical care: a cross-sectional study. (2003) (24)
- Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial. (2017) (24)
- Studying the Effects of Reproductive Hormones and Bacterial Vaginosis on the Glycome of Lavage Samples from the Cervicovaginal Cavity (2015) (24)
- FAME‐04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir (2018) (24)
- Randomized Trial of Antibiotics in Addition to Tocolytic Therapy to Treat Preterm Labor (1994) (23)
- Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. (2017) (23)
- Subtle perturbations of genital microflora alter mucosal immunity among low‐risk pregnant women (2011) (23)
- Lipopolysaccharide binding protein and soluble CD14 receptor protein in amniotic fluid and cord blood in patients at term. (1997) (22)
- Cervical Cytokines Associated With Chlamydia trachomatis Susceptibility and Protection. (2019) (22)
- A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III. (2018) (22)
- 0.25% Chlorhexidine Gluconate Gel: A Protective Topical Microbicide (1998) (22)
- Evaluation of the Affirm Ambient Temperature Transport System for the Detection and Identification ofTrichomonas vaginalis, Gardnerella vaginalis, andCandida Species from Vaginal Fluid Specimens (2001) (22)
- Susceptibility of vaginal bacteria to metronidazole and tinidazole. (2006) (22)
- Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. (2012) (21)
- Longitudinal Reliability of Focus Glycoprotein G-Based Type-Specific Enzyme Immunoassays for Detection of Herpes Simplex Virus Types 1 and 2 in Women (2003) (21)
- Why Nonoxynol-9 May Have Failed to Prevent Acquisition of Neisseria gonorrhoeae in Clinical Trials (2005) (21)
- Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides. (2006) (21)
- Characterization of unusual tetracycline-resistant gram-positive bacteria (1991) (21)
- Characterization of vaginal & rectal colonization with multiple serotypes of group B streptococci using multiple colony picks. (2004) (21)
- Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women (2017) (20)
- Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates. (2004) (20)
- Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel. (2016) (20)
- Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. (2016) (20)
- Susceptibility of Upper‐Genital Tract Isolates from Women with Pelvic Inflammatory Disease to Ampicillin, Cefpodoxime, Metronidazole, and Doxycycline (1991) (20)
- Plasma versus Serum for Detection of Herpes Simplex Virus Type 2-Specific Immunoglobulin G Antibodies with a Glycoprotein G2-Based Enzyme Immunoassay (2003) (20)
- Metronidazole for Bacterial Vaginosis (1986) (19)
- Effect of Chlorhexidine on Genital Microflora, Neisseria gonorrhoeae, and Trichomonas vaginalis In Vitro (2000) (19)
- Use of DNA hybridization to detect vaginal pathogens associated with bacterial vaginosis among asymptomatic pregnant women. (2005) (19)
- Infection of Cells with Varicella-Zoster Virus Down-Regulates Surface Expression of Class I Major Histocompatibility Complex Antigens (1998) (19)
- Women's perspectives on human papillomavirus self‐sampling in the context of the UK cervical screening programme (2017) (18)
- Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women. (2020) (18)
- Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study (2015) (18)
- Misreporting of contraceptive hormone use in clinical research participants (2016) (18)
- Vaginal myeloperoxidase and flora in the pig-tailed macaque. (2000) (17)
- Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell Response Against Chlamydia (TRAC) Study (2018) (17)
- Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure. (2013) (17)
- A little bit pregnant: modeling how the accurate detection of pregnancy can improve HIV prevention trials. (2008) (16)
- Gene Expression Signatures Can Aid Diagnosis of Sexually Transmitted Infection-Induced Endometritis in Women (2018) (16)
- Misreporting of contraceptive hormone use in clinical research participants. (2016) (16)
- Evaluation of the enhanced rapid identification method for Gardnerella vaginalis (1989) (15)
- Use of Nucleic Acid Amplification Testing for Diagnosis of Extragenital Sexually Transmitted Infections (2017) (15)
- Neonatal blood TSH concentration in Wales (UK): an indicator of iodine sufficiency (2014) (15)
- Systemic Immune Response to Trichomonas vaginalis Infection During Pregnancy (2006) (15)
- Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies. (2011) (15)
- Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial (2017) (15)
- Women Receiving Group B Streptococcus Serotype III Tetanus Toxoid (GBS III-TT) Vaccine Have Reducesd Vaginal and Rectal Acquisition of GBS Type III (2009) (15)
- Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease (2018) (15)
- Etiology and treatment of post-cesarean-section endometritis after cephalosporin prophylaxis. (1990) (14)
- Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals? (2016) (14)
- Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women (2015) (14)
- Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003) (2017) (14)
- Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring (2019) (14)
- Comprehensive Molecular Serology of Human Chlamydia trachomatis Infections by Peptide Enzyme-Linked Immunosorbent Assays (2018) (14)
- Humoral antibody to Mobiluncus curtisii, a potential serological marker for bacterial vaginosis (1996) (13)
- Combined Hormonal Contraception May Be Protective Against Neisseria gonorrhoeae Infection (2010) (13)
- Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High‐risk African Women (2019) (13)
- Newborn screening for sickle cell disorders using tandem mass spectrometry: three years’ experience of using a protocol to detect only the disease states (2017) (13)
- Comparison of Clindamycin Phosphate Vaginal Cream With Triple Sulfonamide Vaginal Cream in the Treatment of Bacterial Vaginosis (2001) (13)
- Production and characterization of monoclonal antibodies to Mobiluncus species (1988) (13)
- Elevated Risk of Bacterial Vaginosis among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study. (2020) (13)
- Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial. (2019) (12)
- Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women. (2017) (12)
- The severity of fetal membrane infection and pregnancy complications. (1993) (12)
- Ampicillin susceptibilities of vaginal and placental isolates of group B streptococcus and Escherichia coli obtained between 1992 and 1994 (1997) (12)
- Haemophilus influenzae septic abortion. (2002) (11)
- Characteristics of the vaginal microbiome in women with and without clinically confirmed vulvodynia. (2020) (11)
- Discovery of Human-Specific Immunodominant Chlamydia trachomatis B Cell Epitopes (2018) (11)
- The Safety, Persistence, and Acceptability of an Antiretroviral Microbicide Candidate UC781 (2012) (11)
- Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial. (2019) (11)
- Survival of vaginal microorganisms in three commercially available transport systems. (2017) (10)
- Mixed Chlamydia trachomatis Peptide Antigens Provide a Specific and Sensitive Single-Well Colorimetric Enzyme-Linked Immunosorbent Assay for Detection of Human Anti-C. trachomatis Antibodies (2018) (9)
- Preventing neonatal Group B streptococcal disease: The role of the clinical microbiology laboratory (1997) (9)
- Zim CHIC: A cohort study of immune changes in the female genital tract associated with initiation and use of contraceptives (2020) (9)
- In vitro activity of cationic peptides against Neisseria gonorrhoeae and vaginal Lactobacillus species: The effect of divalent cations (2012) (9)
- Comparison of Three Wash Techniques for the Removal of Microorganisms From Semen (1987) (9)
- Anti‐chlamydia IgG and IgA are insufficient to prevent endometrial chlamydia infection in women, and increased anti‐chlamydia IgG is associated with enhanced risk for incident infection (2019) (9)
- Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia. (2021) (9)
- Genomic DNA fingerprint analysis of biotype 1 Gardnerella vaginalis from patients with and without bacterial vaginosis (1996) (9)
- A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease. (2021) (9)
- Megasphaera lornae sp. nov., Megasphaera hutchinsoni sp. nov., and Megasphaera vaginalis sp. nov.: novel bacteria isolated from the female genital tract. (2019) (9)
- Vaginal Product Formulation Alters the Innate Antiviral Activity and Glycome of Cervicovaginal Fluids with Implications for Viral Susceptibility. (2018) (9)
- Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa (2011) (9)
- [Prevalence of bacterial vaginosis in an obstetric population of Barcelona]. (1998) (8)
- The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition. (2019) (8)
- Diagnosis and clinical manifestiations of bacterial vaginosis (1989) (8)
- Advances in diagnostic testing for vaginitis and cervicitis. (1989) (7)
- HIV prevention: better choice for better coverage (2022) (7)
- Implementation of a fidelity monitoring process to assess delivery of an evidence-based adherence counseling intervention in a multi-site biomedical HIV prevention study (2020) (7)
- Levels of Genital Tract Defensins and Cytokines Differ between HIV‐Uninfected US and African Women (2015) (7)
- Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35–39 at Increased Familial Risk of Breast Cancer (2019) (7)
- Comparison of the use of oligonucleotide probes, 4-methylumbelliferyl derivatives, and conventional methods for identifying Prevotella bivia. (1995) (7)
- Identification of two new antigenic subgroups within the genus Mobiluncus (1991) (7)
- Prevalence of candida africana among women with Vulvovaginal Candidiasis (VVC) and/or Bacterial Vaginosis (BV) in the United States: 6 (2017) (7)
- Inactivation of Herpes Simplex Virus Clinical Isolates by Using a Combination Microbicide (2006) (7)
- Preferred characteristics of vaginal microbicides in women with bacterial vaginosis. (2009) (6)
- Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study. (2019) (6)
- A Phase One Pharmacokinetic Study of Ledipasvir/Sofosbuvir in Pregnant Women with Hepatitis C Virus (2020) (6)
- Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials (2018) (6)
- Prevalent, treatable and significant: barriers to the control of Trichomonas vaginalis in women (2013) (6)
- Clinical and population‐based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy (2022) (5)
- Feasibility and Safety of IUD Insertion by Mid-Level Providers in Sub-Saharan Africa. (2019) (5)
- 14: Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole, metronidazole, tinidazole and clindamycin (2016) (5)
- Detectable Tenofovir Levels in Breast-Feeding Infants of Mothers Exposed to Topical Tenofovir (2016) (5)
- Human immunodeficiency virus type-1 infection associated with vaginal flora morphology and bacterial vaginosis (BV) (1997) (5)
- Broad-spectrum bacterial ribosomal rna polymerase chain reaction for the detection of amniotic fluid infection among women in preterm labor (1996) (5)
- Containing antibiotic resistance: demonstration of decreased antibiotic resistant coliform urinary tract infections with reduction in antibiotic prescribing by general medical practices (2007) (5)
- Lea's Shield: colposcopic and microbiological testing during 8 weeks of use. (2005) (5)
- Demonstration of heterogeneity among the antigenic proteins of Mobiluncus species (1990) (5)
- Preventing the sexual transmission of HIV-1 with topical microbicides: another piece of the equation. (2007) (5)
- Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls. (2020) (4)
- Dapivirine Vaginal Ring for HIV-1 Prevention. (2017) (4)
- Vaginal colonization in four ethnic groups (1995) (4)
- THE ASSOCIATION OF UREAPLASMA UREALYTICUM WITH PRETERM BIRTH, CHORIOAMNIONITIS, POSTPARTUM FEVER, INTERAPARTUM FEVER AND BACTERIAL VAGINOSIS (1986) (3)
- Characterization of novel megasphaera species from the female reproductive tract: 12 (2018) (3)
- Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study. (2019) (3)
- A retrospective validation of the FocalPoint GS slide profiler NFR technology by analysis of interval disease outcomes compared with manual cytology (2019) (3)
- Effect of injectable progestin‐only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T‐cell activation (2021) (3)
- Expression, activity, and regulation of phosphorylating enzymes in tissues and cells relevant to HIV-1 sexual transmission. (2021) (3)
- Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data (2020) (3)
- Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial Vaginosis (2022) (3)
- Colposcopically Obtained Images of Vulvar, Vaginal, and Cervical Epithelium for Assessment of Safety of Intravaginal Agents Among Normal Adolescent Females: Comparison with In Vivo Exam and Interobserver Agreement (2003) (3)
- A thermodynamic study of the cyclodextrin-UC781 inclusion complex using a HPLC method (2012) (3)
- 6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis (2015) (3)
- Host Genetic Risk Factors for Chlamydia trachomatis-Related Infertility in Women. (2021) (3)
- A longitudinal evaluation of the impact of contraceptive initiation on vaginal microbiota in us women: 22 (2018) (3)
- Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel (2012) (3)
- Tenofovir-Based Pre-exposure for HIV Infection among African Women (2014) (3)
- Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31]. (2016) (2)
- O18.2 Injectable progestin contraception and acquisition of hsv-2 infection among south african women participating in the voice trial (2015) (2)
- O05.1 Lower genital tract predictors of acute endometritis among women with signs and symptoms of pelvic inflammatory disease (PID) (2019) (2)
- Microbial and Clinical Correlations in Evaluation of Preterm Birth (1988) (2)
- A little bit pregnant: the challenges of diagnosing pregnancy in microbicide trials (2006) (2)
- Nucleic Acid Amplification Testing Compared With Cultures, Gram Stain, and Microscopy in the Diagnosis of Vaginitis (2021) (2)
- Anal intercourse, HIV-1 risk, and efficacy in a trial of a dapivirine-containing vaginal ring for HIV-1 prevention. (2019) (2)
- A pharmacokinetic and treatment study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus (2019) (2)
- Expression of Group B Protective Surface Protein (BPS) by Invasive and Colonizing Isolates of Group B Streptococci (2014) (2)
- Correction: Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators (2012) (2)
- Comparison ofMethodsforDiagnosing Bacterial Vaginosis among Pregnant Women (1989) (1)
- Comparative Study of Intravaginal Metronidazole and Triple-Sulfa Therapy for Bacterial Vaginosis (1996) (1)
- Preterm Birth and Cervicovaginal Microbiologic‐Host Interactions (1988) (1)
- Reduced Endometrial Ascension and Enhanced Reinfection Associated with IgG Antibodies to Specific Chlamydia trachomatis Proteins in Women at Risk for Chlamydia. (2021) (1)
- Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T‐cell responses and expression of immunosuppressive markers (2019) (1)
- 413 Lower genital tract infection, racial group and risk of preterm delivery of a low birthweight infant (2001) (1)
- Vaginal Ecology in Pregnancy (1999) (1)
- A phase I randomized safety study of a single-size silicone rubber diaphragm used with or without a lactic-acid-containing diaphragm gel. (2019) (1)
- Cervical anti-inflammatory cytokine concentrations are decreased among pregnant women with bacterial vaginosis (2004) (1)
- Antenatal microbiologic and maternal risk factors associated with prematurity (1991) (1)
- Treating asymptomatic bacterial vaginosis in pregnancy (2002) (1)
- Co-expression network analysis reveals immune response pathways important for pathogenesis of Chlamydial pelvic inflammatory disease (PID). (HUM8P.329) (2014) (1)
- S5.2 Action heroes or casual observers: vaginal microflora and STI/HIV risk (2011) (1)
- THE RELATIONSHIP BETWEEN LOWER-AND UPPER-GENITAL-TRACT INFECTION IN PREGNANCY (1999) (1)
- Detection and Localisation of Sialic Acid in Gardnerella vaginalis, Mobiluncus spp., and Other Vaginal Microorganisms (1989) (1)
- O01.4 Blood Transcriptional Profiling of Women with Chlamydia Trachomatis Identifies a Pelvic Inflammatory Disease (PID) Signature (2013) (1)
- 1: Fewer cervical immune cells in women with abnormal vaginal microbiota compared to women with normal vaginal microbiota (2016) (1)
- 2: Longitudinal study evaluating the impact of hormonal contraception on vaginal microflora patterns (2015) (1)
- Impact of Microbicide Formulation on Glycosylation and Innate Immunity in Cervicovaginal Fluid (2016) (1)
- Pre-Exposure Prophylaxis to Prevent HIV Transmission (2011) (1)
- Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa (2021) (1)
- Elevated risk of bacterial vaginosis among copper intrauterine device users: a prospective cohort analysis (2019) (0)
- Antepartum drug abuse and preterm delivery of a low birth weight infant (1996) (0)
- Identification of Chlamydia trachomatis proteins recognized by T cells from high-risk women resistant to reinfection and/or protected from ascending infection. (VAC7P.961) (2014) (0)
- Association between easily observed membrane roll characteristics and high amniotic fluid interleukin-6 levels among patients delivering prematurely (1996) (0)
- A Microbicide Perspective: Past, Present, and Future (2009) (0)
- MTN-033: a Phase 1 Study Comparing Applicator versus “as Lubricant” Delivery of Rectal Dapivirine Gel (2022) (0)
- The relationship between periodontal disease and bacterial vaginosis among pregnant women (2004) (0)
- Reliability ofDiagnosing Bacterial Vaginosis IsImprovedbya Standardized MethodofGramStain Interpretation (1991) (0)
- P06.08 The association between free glycogen in the vaginal fluid and colonisation by lactobacilli (2015) (0)
- P587 Association between vaginal bacteria and HIV acquisition risk among african women participating in the VOICE study (2019) (0)
- P365 Microbial risk factors for acquisition of symptomatic Bacterial Vaginosis (BV) (2019) (0)
- Elevated vaginal pH and neutrophils are associated with early preterm premature rupture of membranes (2003) (0)
- Experiences with simultaneous use of contraception and the vaginal ring for HIV prevention in sub-Saharan Africa (2021) (0)
- Erratum: Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy (American Journal of Obstetrics and Gynecology (2003) 189 (560-507)) (2003) (0)
- Erratum (2000) (0)
- O03.5 PID Treatment and Mycoplasma genitalium (MG): The Impact of Vaginal Dysbiosis (2021) (0)
- Update on prevention of mother-to-child HIV transmission (2014) (0)
- When normal isn't normal: heterogeneity in dominant lactobacillus species among women having a nugent score of 0-3 (2019) (0)
- 4 HIV Prevention Research: Progress and Challenges (2014) (0)
- Use of Nucleic Acid Amplification Testing for the Diagnosis of Extragenital Sexually Transmitted Infections: NAAT DETECTION OF STIS IN RECTAL AND PHARYNGEAL SWABS (2017) (0)
- Optimization of processing female genital tissue samples for lymphocyte analysis by flow cytometry (2020) (0)
- Screening for lower genital tract pathogens in the ob patient (1997) (0)
- Barrier-Spermicide Use and Bacteriuria-Reply (1991) (0)
- 8: A comparison of real time PCR and culture for the quantitative detection of selected vaginal microbiota (2015) (0)
- The Hope and Progress in Microbicides and Pre-Exposure Prophylaxis to Prevent HIV (2010) (0)
- Biology of mucosal transmission of HIV in the genital tract (2001) (0)
- Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women (2016) (0)
- Vaginal lactobacilli, mierobial of Lactobacillus products used for colonization of the vaginal (1999) (0)
- S04.1: Single cell transcriptomic analysis reveals dynamic placental immunomodulation by GBS during pregnancy (2022) (0)
- Association ofViridans GroupStreptococci fromPregnant Women withBacterial Vaginosis andUpperGenital TractInfection (1988) (0)
- Original research article Lea's ShieldR: colposcopic and microbiological testing during 8 weeks of use (2005) (0)
- Identification of CPAF as the immunoprevalent antigen of Chlamydia trachomatis (2022) (0)
- 10: What is normal? deciphering nugent scores of 0-3 in US and Zimbabwean women (2016) (0)
- P07.09 A validation study of the cepheid xpertâ ct/ng for detecting chlamydia trachomatis and neisseria gonorrhoeae in rectal samples (2015) (0)
- 5: Marked increase in cervical CD8 cells following human immunodeficiency virus seroconversion (2016) (0)
- within the genus Mobiluncus. Identification of two new antigenic subgroups (2013) (0)
- P366 An evaluation of the BD MAX™ vaginal panel compared to the nugent score for diagnosis of bacterial vaginosis (BV) (2019) (0)
- Evaluation of vaginal swab specimens for detection of Neisseria gonorrhoeae and Chlamydia trachomatis by BDProbeTec ET (2001) (0)
- Symptoms associated with chlamydial infection among minority women (2014) (0)
- Screening for undiagnosed diabetes in the first trimester of pregnancy: a summary of the evidence (2017) (0)
- M ageeibacillus (2019) (0)
- Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials. (2022) (0)
- Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females. (2021) (0)
- 25: Mycoplasma genitalium and acute pelvic inflammatory disease (2016) (0)
- 5: Injectable progestin contraception and vaginal infection among south african women participating in the VOICE trial (2015) (0)
- Genetic susceptibility loci for Chlamydia trachomatis endometrial infection influence expression of genes involved in T cell function, tryptophan metabolism and epithelial integrity (2022) (0)
- Clinical practice and accuracy of vaginitis diagnosis in community based settings: 16 (2018) (0)
- The effects of reproductive hormones on the viscosity and PH of cervicovaginal fluid (2013) (0)
- 633: Maternal inflammatory mediators are increased as early as the first trimester in low risk pregnancies (2009) (0)
- O13.1 The broad diversity of cultivable microbiota in pregnant women and the detection of novel organisms (2015) (0)
- S03.5 (Oral Abstract Presentation): Benzene exposure during pregnancy leads to respiratory viral infection sensitivity in adult offspring (2022) (0)
- Influences of vaginal and embryo transfer catheter microbiology on early pregnancy loss following in vitro fertilization (2003) (0)
- Expression of Group B Protective Surface Protein (BPS) by Invasive and Colonizing Isolates of Group B Streptococci (2014) (0)
- De Douching , Pelvic Inflammatory Disease , and Incident Gonococcal and Chlamydial Genital Infection in a Cohort of High-Risk Women (2004) (0)
- Maternal group b streptococcal (GBS) culture status of infants GBS positive at delivery (1996) (0)
- Acceptability of Single-Dose Clindamycin Gel for Bacterial Vaginosis: A Randomized Controlled Trial. (2023) (0)
- Diagnostic accuracy of clinical criteria for bacterial vaginosis, vulvovaginal candidiasis and BV/VVC co-infections (2019) (0)
- 8: Demographic characteristics, obstetric and neonatal outcomes of pregnant women infected with hepatitis C virus (2016) (0)
- Microbicides: Shots in the Dark or Rays of Hope (2005) (0)
- P3.449* The promise of estriol cream for prevention of vaginal infection in premenopausal women (2013) (0)
- 18: Differences in patterns of extragenital chlamydia and gonorrhea in men and women (2015) (0)
- OTU-026 Feasibility & economic evaluation – chromoendoscopy for detecting proximal serrated neoplasia: randomised controlled trial, conscop (2018) (0)
- Genetic BasisofTetracycline Resistance inUrogenital Bacteria (1990) (0)
- Pediatric hepatitis C virus screening: room for improvement: 9 (2017) (0)
- OTU-021 EFFECT OF THE TWO-WEEK WAIT REFERRAL PATHWAY ON COLORECTAL CANCER DETECTION : SYSTEMATIC REVIEW AND META-ANALYSIS 1 (0)
- EffEcts of AbnormAl VAginAl florA And mEnoPAusE on cErVicoVAginAl fluid Viscosity doi:10.1136/sextrans-2013-051184.0246 (2013) (0)
- A Clinical Update In Treatment of Bacterial Vaginosis (2004) (0)
- 15: The endometrial microflora of women with histologic endometritis without symptoms of pelvic inflammatory disease (2015) (0)
- Charlene Susan Dezzutti (1964-2018) Virologist with a Passion for HIV Prevention. (2018) (0)
- 5 – Vaginal Infections (2010) (0)
- Douching and Endometritis (2001) (0)
- Topical Microbicides for Human Immunodeficiency Virus and Sexually Transmitted Disease Prevention (2013) (0)
- Association of vaginal hydrolytic enzymes with amniotic fluid proinflammatory cytokines among women in preterm labor (2004) (0)
- 5: Microbiological etiology of symptomatic versus subclinical pelvic inflammatory disease (2016) (0)
- Effect of contraceptive method on Vaginal Flora (1996) (0)
- Sexually associated Group B streptococcal subtype colonization (2004) (0)
- Abnormal GGT Levels; Identifying Clue Cells (1998) (0)
- Brief Report: Dapivirine Ring HIV-1 Prevention Effectiveness for Women Engaged in Vaginal and Anal Intercourse: Insights From Mathematical Modeling (2022) (0)
- Tu2012 - Feasibility and Economic Evaluation of Chromoendoscopy for Detecting Proximal Serrated Neoplasia in a Colorectal Cancer Screening Program: A Randomised Control Trial – Conscop (2018) (0)
- Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV Prevention (2022) (0)
- Formulation and Characterization of Polymeric Films Containing Combinations of Antiretrovirals (ARVs) for HIV Prevention (2014) (0)
- Multidimensional phenotypic immune profiling of Chlamydia trachomatis infected women using mass cytometry platform. (2018) (0)
- Vaginal inflammation and secretory leukocyte protease inhibitor among women with bacterialvaginosis in early pregnancy : spons to antibiotic treatment S 19 vaginosis in early pregnancy : response to antibiotic treatment (2014) (0)
- Zim CHIC: impact of contraceptive initiation on vaginal microbiota: 11 (2017) (0)
- Increased levels of Th1-inducing cytokines are detected in cervical secretions of women with Chlamydia trachomatis infection limited to their cervix (2018) (0)
- 7: Is more always better? comparing nucleic acid amplification testing to traditional methods in diagnosis of vaginal infections in gynecology and vulvovaginal referral offices (2015) (0)
This paper list is powered by the following services:
Other Resources About Sharon Hillier
What Schools Are Affiliated With Sharon Hillier?
Sharon Hillier is affiliated with the following schools:
